vs
Side-by-side financial comparison of FEDERAL SIGNAL CORP (FSS) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
FEDERAL SIGNAL CORP is the larger business by last-quarter revenue ($597.1M vs $339.0M, roughly 1.8× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs 10.2%, a 3.0% gap on every dollar of revenue. On growth, FEDERAL SIGNAL CORP posted the faster year-over-year revenue change (26.5% vs -2.7%). FEDERAL SIGNAL CORP produced more free cash flow last quarter ($89.5M vs $87.2M). Over the past eight quarters, FEDERAL SIGNAL CORP's revenue compounded faster (18.5% CAGR vs 0.4%).
The Federal Signal Company was an American manufacturer of railway signaling equipment in the early 20th century. It was located in Albany, New York.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
FSS vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $597.1M | $339.0M |
| Net Profit | $60.8M | $44.7M |
| Gross Margin | 28.4% | 59.7% |
| Operating Margin | 14.0% | 19.9% |
| Net Margin | 10.2% | 13.2% |
| Revenue YoY | 26.5% | -2.7% |
| Net Profit YoY | 21.6% | 19.3% |
| EPS (diluted) | $0.99 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $597.1M | $339.0M | ||
| Q3 25 | $555.0M | $327.3M | ||
| Q2 25 | $564.6M | $321.4M | ||
| Q1 25 | $463.8M | $330.6M | ||
| Q4 24 | $472.0M | $348.5M | ||
| Q3 24 | $474.2M | $345.5M | ||
| Q2 24 | $490.4M | $336.2M | ||
| Q1 24 | $424.9M | — |
| Q4 25 | $60.8M | $44.7M | ||
| Q3 25 | $68.1M | $38.7M | ||
| Q2 25 | $71.4M | $34.0M | ||
| Q1 25 | $46.3M | $58.0M | ||
| Q4 24 | $50.0M | $37.5M | ||
| Q3 24 | $53.9M | $33.8M | ||
| Q2 24 | $60.8M | $38.4M | ||
| Q1 24 | $51.6M | — |
| Q4 25 | 28.4% | 59.7% | ||
| Q3 25 | 29.1% | 59.5% | ||
| Q2 25 | 30.0% | 59.8% | ||
| Q1 25 | 28.2% | 58.4% | ||
| Q4 24 | 28.1% | 55.5% | ||
| Q3 24 | 29.6% | 54.2% | ||
| Q2 24 | 29.4% | 52.0% | ||
| Q1 24 | 27.3% | — |
| Q4 25 | 14.0% | 19.9% | ||
| Q3 25 | 16.9% | 17.9% | ||
| Q2 25 | 17.3% | 16.8% | ||
| Q1 25 | 14.2% | 21.6% | ||
| Q4 24 | 14.9% | 16.9% | ||
| Q3 24 | 16.0% | 15.0% | ||
| Q2 24 | 16.5% | 11.8% | ||
| Q1 24 | 12.8% | — |
| Q4 25 | 10.2% | 13.2% | ||
| Q3 25 | 12.3% | 11.8% | ||
| Q2 25 | 12.6% | 10.6% | ||
| Q1 25 | 10.0% | 17.5% | ||
| Q4 24 | 10.6% | 10.8% | ||
| Q3 24 | 11.4% | 9.8% | ||
| Q2 24 | 12.4% | 11.4% | ||
| Q1 24 | 12.1% | — |
| Q4 25 | $0.99 | $0.95 | ||
| Q3 25 | $1.11 | $0.81 | ||
| Q2 25 | $1.16 | $0.70 | ||
| Q1 25 | $0.75 | $1.17 | ||
| Q4 24 | $0.80 | $0.74 | ||
| Q3 24 | $0.87 | $0.66 | ||
| Q2 24 | $0.99 | $0.74 | ||
| Q1 24 | $0.84 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.7M | $363.4M |
| Total DebtLower is stronger | $564.6M | $1.2B |
| Stockholders' EquityBook value | $1.4B | $911.5M |
| Total Assets | $2.4B | $2.5B |
| Debt / EquityLower = less leverage | 0.41× | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $363.4M | ||
| Q3 25 | $54.4M | $296.4M | ||
| Q2 25 | $64.7M | $292.9M | ||
| Q1 25 | $57.5M | $306.8M | ||
| Q4 24 | $91.1M | $320.8M | ||
| Q3 24 | $73.7M | $299.3M | ||
| Q2 24 | $48.6M | $344.4M | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $564.6M | $1.2B | ||
| Q3 25 | $201.2M | $1.2B | ||
| Q2 25 | $258.3M | $1.2B | ||
| Q1 25 | $266.9M | $1.2B | ||
| Q4 24 | $204.4M | — | ||
| Q3 24 | $223.3M | — | ||
| Q2 24 | $248.8M | — | ||
| Q1 24 | $266.8M | — |
| Q4 25 | $1.4B | $911.5M | ||
| Q3 25 | $1.3B | $849.2M | ||
| Q2 25 | $1.3B | $882.3M | ||
| Q1 25 | $1.2B | $820.8M | ||
| Q4 24 | $1.2B | $906.9M | ||
| Q3 24 | $1.1B | $878.9M | ||
| Q2 24 | $1.1B | $905.4M | ||
| Q1 24 | $1.0B | — |
| Q4 25 | $2.4B | $2.5B | ||
| Q3 25 | $1.9B | $2.4B | ||
| Q2 25 | $1.9B | $2.5B | ||
| Q1 25 | $1.9B | $2.5B | ||
| Q4 24 | $1.8B | $2.5B | ||
| Q3 24 | $1.7B | $2.5B | ||
| Q2 24 | $1.7B | $2.5B | ||
| Q1 24 | $1.7B | — |
| Q4 25 | 0.41× | 1.34× | ||
| Q3 25 | 0.15× | 1.44× | ||
| Q2 25 | 0.20× | 1.39× | ||
| Q1 25 | 0.22× | 1.49× | ||
| Q4 24 | 0.17× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | 0.26× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $97.2M | $93.6M |
| Free Cash FlowOCF − Capex | $89.5M | $87.2M |
| FCF MarginFCF / Revenue | 15.0% | 25.7% |
| Capex IntensityCapex / Revenue | 1.3% | 1.9% |
| Cash ConversionOCF / Net Profit | 1.60× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | $227.1M | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.2M | $93.6M | ||
| Q3 25 | $61.1M | $111.3M | ||
| Q2 25 | $59.7M | $17.4M | ||
| Q1 25 | $36.7M | $116.6M | ||
| Q4 24 | $90.6M | $43.8M | ||
| Q3 24 | $68.8M | $48.8M | ||
| Q2 24 | $40.6M | $-27.4M | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $89.5M | $87.2M | ||
| Q3 25 | $54.1M | $106.3M | ||
| Q2 25 | $52.4M | $13.6M | ||
| Q1 25 | $31.1M | $100.9M | ||
| Q4 24 | $82.1M | $35.2M | ||
| Q3 24 | $60.9M | $39.4M | ||
| Q2 24 | $24.8M | $-33.1M | ||
| Q1 24 | $22.9M | — |
| Q4 25 | 15.0% | 25.7% | ||
| Q3 25 | 9.7% | 32.5% | ||
| Q2 25 | 9.3% | 4.2% | ||
| Q1 25 | 6.7% | 30.5% | ||
| Q4 24 | 17.4% | 10.1% | ||
| Q3 24 | 12.8% | 11.4% | ||
| Q2 24 | 5.1% | -9.8% | ||
| Q1 24 | 5.4% | — |
| Q4 25 | 1.3% | 1.9% | ||
| Q3 25 | 1.3% | 1.5% | ||
| Q2 25 | 1.3% | 1.2% | ||
| Q1 25 | 1.2% | 4.7% | ||
| Q4 24 | 1.8% | 2.5% | ||
| Q3 24 | 1.7% | 2.7% | ||
| Q2 24 | 3.2% | 1.7% | ||
| Q1 24 | 2.0% | — |
| Q4 25 | 1.60× | 2.09× | ||
| Q3 25 | 0.90× | 2.88× | ||
| Q2 25 | 0.84× | 0.51× | ||
| Q1 25 | 0.79× | 2.01× | ||
| Q4 24 | 1.81× | 1.17× | ||
| Q3 24 | 1.28× | 1.44× | ||
| Q2 24 | 0.67× | -0.71× | ||
| Q1 24 | 0.61× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSS
| Vehiclesandequipment | $403.4M | 68% |
| Parts | $66.8M | 11% |
| Publicsafetyandsecurityequipment | $62.2M | 10% |
| Rentalincome | $19.0M | 3% |
| Industrialsignalingequipment | $18.2M | 3% |
| Other | $14.9M | 2% |
| Warningsystems | $12.6M | 2% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
